3//SEC Filing
Access Industries Holdings LLC 3
Accession 0001209191-18-039545
CIK 0001694187other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:00 PM ET
Size
19.5 KB
Accession
0001209191-18-039545
Insider Transaction Report
Form 3
Holdings
Series B Preferred Stock
→ Common Stock (782,917 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)
Blavatnik Len
Other
Holdings
Series A Preferred Stock
→ Common Stock (999,998 underlying)Series B Preferred Stock
→ Common Stock (782,917 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)
Holdings
Series B Preferred Stock
→ Common Stock (782,917 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)
Access Industries Holdings LLC
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (999,998 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)Series B Preferred Stock
→ Common Stock (782,917 underlying)
Holdings
Series A Preferred Stock
→ Common Stock (999,998 underlying)Series A Preferred Stock
→ Common Stock (999,998 underlying)Series B Preferred Stock
→ Common Stock (782,917 underlying)
Footnotes (4)
- [F1]Each share of Series A Preferred Stock is currently convertible into shares of the Issuer's common stock, $0.001 par value per share ("Common Stock") on approximately a 5:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock will convert into shares of Common Stock of the Issuer. The Series A Preferred Stock has no expiration date.
- [F2]The securities reported are held directly by Access Industries Holdings LLC ("AIH") and may be deemed to be beneficially owned by Access Industries, LLC ("Access LLC"), Access Industries Management, LLC ("Management LLC") and Len Blavatnik, because Access LLC holds a majority of the outstanding voting interests in AIH, Management LLC controls Access LLC and AIH, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than AIH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of such securities for any purpose.
- [F3]The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons, other than CBI, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.
- [F4]Each share of Series B Preferred Stock is currently convertible into shares of the Issuer's Common Stock on approximately a 5:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock will convert into shares of Common Stock of the Issuer. The Series B Preferred Stock has no expiration date.
Issuer
Neon Therapeutics, Inc.
CIK 0001694187
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001391297
Filing Metadata
- Form type
- 3
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:00 PM ET
- Size
- 19.5 KB